Recall Register

Food, drugs, devices › Alere San Diego, Inc.

Device recall: Alere Cholestech LDX ALT AST Test Cassette, Model #12-788. For the in vitro quantitative determination of alanine aminot

FDA enforcement event 64671 · Class II · initiated 6 Mar 2013 · status Terminated · terminated 13 Aug 2013

DeviceVoluntary: Firm initiated1 product recordSan Diego, CA

FDA enforcement event 64671 is a device recall by Alere San Diego, Inc. of San Diego, CA, initiated 6 Mar 2013 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 90% of the 1,236 device enforcement events initiated in 2013 carry the same class.

Status: Terminated, terminated 13 Aug 2013. Initiation: voluntary: firm initiated. Alere San Diego, Inc. has 28 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Alere San Diego, Inc., San Diego, CA.

Reason for recall

"The recall was initiated because Alere San Diego has an update for the Alere Cholestech LDX ALT AST cassette, and it has the potential for humidity changes to impact results for certain analytes on the Alere Cholestech LDX System."

Distribution

"Worldwide Distribution-USA (nationwide) and the countries of Canada, South Africa, Netherlands, Italy, Brazil, Singapore, Russia, Hong Kong, Argentina, South Korea, Philippines, El Salvador,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1139-2013Alere Cholestech LDX ALT AST Test Cassette, Model #12-788. For the in vitro quantitative determination of alanine aminotransferase (ALT) and aspartate aminotransferase (AST).38,571 kitsClass IITerminated24 Apr 2013

Context

90%of 2013 device events are Class II1,236 events that year
1product record in this eventfirm median: 1
28events on this register for the firm

Other enforcement events for Alere San Diego, Inc.

InitiatedProduct (first record)TypeClassRecords
1 Mar 2024Abbott Cholestech LDX Battery Kit, Model: 3LP656194-PCM-LD, PN: 55170DeviceClass II1
24 Jun 2022The Cholestech LDX¿ System combines enzymatic methodology and solidphase technology to measure total cholesterol, HDL chDeviceClass II1
15 Feb 2019Alere Cholestech LDX Analyzer, model # 14-874 containing power supplies with the identifying codes of 1837d and 1843d - DeviceClass II1
14 Nov 2017Triage Drugs of Abuse Plus TCA 25 Test Kit, Model Numbers 92000, 92590, 92591; 25 individually pouched devices, 1 bottleDeviceClass II1
12 Oct 2016Alere Triage Total 5 Control Level 1, Model No. 88753 Description of the product: The Triage Total Controls 5 are qualitDeviceClass II1
2 Aug 2016LDX Optical Check Cassettes (OCC) Model Number: 10-228 and 14-535 Cassette in box with foam insert. The cassette is usedDeviceClass III1
11 Jul 2016Alere INRatio PT/INR System Professional Model Numbers: 0100004 Product Usage: Alere INRatio ¿ 2 PT/INR Monitoring SysteDeviceClass I9
22 Jun 2016Acceava Mono II Rapid Test Strip (Whole Blood, Serum, Plasma), Catalog No. 92404. Mononucleosis Rapid Test Device a simpDeviceClass III7
27 Aug 2015Alere Cholestech LDX Multianalyte Controls, PN 88769 and 88773. Enables users to monitor the performance of total cholesDeviceClass III1
5 Dec 2014Alere INRatio PT/INR Test Strips, Alere INRatio PT/INR System Professional - 0100071 Alere INRatio PT/INR Test Strips, BDeviceClass I3

All 28 events for Alere San Diego, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The recall was initiated because Alere San Diego has an update for the Alere Cholestech LDX ALT AST cassette, and it has the potential for humidity changes to impact results for certain analytes on the Alere Cholestech LDX System."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution-USA (nationwide) and the countries of Canada, South Africa, Netherlands, Italy, Brazil, Singapore, Russia, Hong Kong, Argentina, South Korea, Philippines, El Salvador,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 13 Aug 2013. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.